SMN2 and proximal spinal muscular atrophy: For example, onasemnogene abeparvovec (Zolgensma) treats spinal muscular atrophy (SMA) by delivering a functional SMN1 gene [121], while nusinersen (Spinraza) modifies SMN2 splicing to enhance functional protein levels [122].